[
    [
        {
            "time": "",
            "original_text": "华鑫证券：医药生物板块建议关注基本面稳健、估值相对合理的优质标的",
            "features": {
                "keywords": [
                    "医药生物",
                    "基本面稳健",
                    "估值合理",
                    "优质标的"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华鑫证券：医药生物板块建议关注基本面稳健、估值相对合理的优质标的",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 1,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【行情】眼科医疗板块异动拉升，爱博医疗涨超5%，方盛制药、仁和药业、欧普康视、兴齐眼药等跟涨",
            "features": {
                "keywords": [
                    "眼科医疗",
                    "异动拉升",
                    "爱博医疗",
                    "方盛制药",
                    "仁和药业",
                    "欧普康视",
                    "兴齐眼药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【行情】眼科医疗板块异动拉升，爱博医疗涨超5%，方盛制药、仁和药业、欧普康视、兴齐眼药等跟涨",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "2021年医药行业5月策略报告：短期波动不改长期趋势 仍重点推荐疫苗等",
            "features": {
                "keywords": [
                    "医药行业",
                    "策略报告",
                    "短期波动",
                    "长期趋势",
                    "疫苗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "2021年医药行业5月策略报告：短期波动不改长期趋势 仍重点推荐疫苗等",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 6,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业双周报",
            "features": {
                "keywords": [
                    "医药生物",
                    "双周报"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业双周报",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 4,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "欧普康视拟定增近22亿加速市场渗透 净利三年复合增速达42%",
            "features": {
                "keywords": [
                    "欧普康视",
                    "定增",
                    "市场渗透",
                    "净利复合增速",
                    "42%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "欧普康视拟定增近22亿加速市场渗透 净利三年复合增速达42%",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]